KwdFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « KwdFr.i » - entrée « Tumeurs () »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Tumeurs < Tumeurs () < Tumeurs (anatomopathologie)  Facettes :

List of bibliographic references indexed by Tumeurs ()

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000A95 (2019) Brittney Baer [États-Unis] ; Channing Vail Dudley [États-Unis] ; Rhea Micci Simons [États-Unis]Management Principles Associated With Cytokine Release Syndrome.
000E73 (2019) Priya Hays [États-Unis] ; Caitlin Costello [États-Unis] ; Deepak Asudani [États-Unis]Clinical care of chimeric antigen receptor T-cell patients and managing immune-related adverse effects in the ambulatory and hospitalized setting: a review.
000F01 (2019) Joseph H. Oved [États-Unis] ; David M. Barrett [États-Unis] ; David T. Teachey [États-Unis]Cellular therapy: Immune-related complications.
001348 (2018) Nirmala Chandralega Kampan [Australie] ; Sue D. Xiang [Australie] ; Orla M. Mcnally [Australie] ; Andrew N. Stephens [Australie] ; Michael A. Quinn [Australie] ; Magdalena Plebanski [Australie]Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities.
001351 (2018) Daniel J. Pallin [États-Unis] ; Christopher W. Baugh [États-Unis] ; Michael A. Postow [États-Unis] ; Jeffrey M. Caterino [États-Unis] ; Timothy B. Erickson [États-Unis] ; Gary H. Lyman [États-Unis]Immune-related Adverse Events in Cancer Patients.
001473 (2018) Rossella Talotta [Italie] ; Fabiola Atzeni [Italie] ; Alberto Batticciotto [Italie] ; Maurizio Benucci [Italie] ; Sara Bongiovanni [Italie] ; Piercarlo Sarzi-Puttini [Italie]Biological Agents in Rheumatoid Arthritis: A Cross-Link Between Immune Tolerance and Immune Surveillance.
001622 (2017) Charles SchmidtThe struggle to do no harm in clinical trials.
001685 (2017) José Ram N Maneiro [Espagne] ; Alejandro Souto [Espagne] ; Juan J. Gomez-Reino [Espagne]Risks of malignancies related to tofacitinib and biological drugs in rheumatoid arthritis: Systematic review, meta-analysis, and network meta-analysis.
001754 (2017) Raphaèle Seror [France] ; Xavier Mariette [France]Malignancy and the Risks of Biologic Therapies: Current Status.
002279 (2014) F. Pasquet [France] ; M. Pavic [France] ; J. Ninet [France] ; A. Hot [France][Autoimmune diseases and cancers. Part I: cancers complicating autoimmune diseases and their treatment].
002353 (2014) Sofia Ramiro [Pays-Bas] ; Cécile Gaujoux-Viala ; Jackie L. Nam ; Josef S. Smolen ; Maya Buch ; Laure Gossec ; Désirée Van Der Heijde ; Kevin Winthrop ; Robert LandewéSafety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.
002770 (2013) Haruhiko Hirata ; Satoshi Tetsumoto ; Takashi Kijima ; Hiroshi Kida ; Toru Kumagai ; Ryo Takahashi ; Yasushi Otani ; Koji Inoue ; Hanako Kuhara ; Kazuki Shimada ; Izumi Nagatomo ; Yoshito Takeda ; Sho Goya ; Kazuyuki Yoshizaki ; Ichiro Kawase ; Isao Tachibana ; Tadamitsu Kishimoto ; Atsushi KumanogohFavorable responses to tocilizumab in two patients with cancer-related cachexia.
003462 (2012) Maria A. Lopez-Olivo [États-Unis] ; Jean H. Tayar ; Juan A. Martinez-Lopez ; Eduardo N. Pollono ; Jose Polo Cueto ; M Rosa Gonzales-Crespo ; Stephanie Fulton ; Maria E. Suarez-AlmazorRisk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis.
003503 (2012) Jatinder P. Ahluwalia [États-Unis]Immunotherapy in inflammatory bowel disease.
003570 (2012) Yusuf Yazici [États-Unis] ; Jeffrey R. Curtis [États-Unis] ; Akgun Ince [États-Unis] ; Herbert Baraf [États-Unis] ; Raymond L. Malamet [États-Unis] ; Lichen L. Teng [États-Unis] ; Arthur Kavanaugh [États-Unis]Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
003757 (2012) O. Psenak [Autriche] ; A. Studnicka-Benke [Autriche] ; R. Greil [Autriche]Sicherheit der Immunsuppressiva
003995 (2011) Takao Koike [Japon] ; Masayoshi Harigai [Japon] ; Shigeko Inokuma [Japon] ; Naoki Ishiguro [Japon] ; Junnosuke Ryu [Japon] ; Tsutomu Takeuchi [Japon] ; Syuji Takei [Japon] ; Yoshiya Tanaka [Japon] ; Kyoko Ito [Japon] ; Hisashi Yamanaka [Japon]Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
004433 (????) Melissa Bersanelli [Italie]Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Tumeurs ()" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Tumeurs ()" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Tumeurs ()
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021